Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Urol ; 22(1): 69, 2022 Apr 24.
Article in English | MEDLINE | ID: mdl-35462546

ABSTRACT

INTRODUCTION: Bladder outlet obstruction (BOO) was caused by a series of histological and biochemical changes in the bladder wall, through the inflammation process in the bladder wall, hypertrophy and fibrosis. ADSC has an important role in bladder regeneration. METHODS AND MATERIALS: This study was an experimental randomized study using male Wistar rats which were monitored at 2 and 4 weeks to determine the effect of ADSC therapy on TGF-ß1 type I collagen, and degree of fibrosis. RESULT: Rats were divided into 5 groups. In the week 2 BOO group, 1 sample included in the category of moderate fibrosis, 1 sample that was given ADSC with mild fibrosis category, 3 samples included in severe fibrosis category, 3 samples that were given ADSC included in the category of moderate fibrosis. The concentration of TGF-ß1 in the hADSC therapy group was significantly lower than the control group at the 2nd and 4th week of monitoring (p2 = 0.048, p4 = 0.048), and also with more type I collagen on 2nd and the 4th week (p2 = 0.048, p4 = 0.048). CONCLUSION: ADSC therapy can reduce the concentration of TGF-ß1, type I collagen, and degree of fibrosis in the male Wistar BOO model.


Subject(s)
Mesenchymal Stem Cell Transplantation , Urinary Bladder Neck Obstruction , Animals , Collagen Type I/analysis , Collagen Type I/metabolism , Disease Models, Animal , Female , Fibrosis/metabolism , Fibrosis/therapy , Humans , Male , Mesenchymal Stem Cells , Rats , Rats, Sprague-Dawley , Rats, Wistar , Stem Cells/pathology , Transforming Growth Factor beta1/analysis , Transforming Growth Factor beta1/metabolism , Urinary Bladder/pathology , Urinary Bladder Neck Obstruction/metabolism , Urinary Bladder Neck Obstruction/pathology , Urinary Bladder Neck Obstruction/therapy
2.
F1000Res ; 11: 831, 2022.
Article in English | MEDLINE | ID: mdl-38046538

ABSTRACT

Background: Priapism induces regulation of Transforming Growth Factor-ß1 (TGF-ß1) expression and collagen-type-1 deposition. This will replace the normal corpora cavernosa with fibrotic tissue which eventually resulted in erectile dysfunction. It is also known that the fibrosis process of corpora cavernosa is related to Renin-Angiotensin II System (RAS). Angiotensin II receptor blockers (ARB), especially losartan, inhibit the inflammation process and fibrotic tissue formation. This study evaluated the effect of losartan in reducing fibrosis in priapism by evaluating TGF-ß1 and collagen-type-1 in cavernous tissue and determined the effect of losartan in preventing fibrosis in priapism model of Wistar rats assessed by the metavir score. Methods: A total of eighteen male Wistar rats mean were divided into five groups. For the priapism models, we applied negative pressure on the penis to make an artificial erection to mimic the priapism process. The control groups were observed and the treatment groups were orally given losartan 15 mg/kg/day. Corpora cavernosa was harvested for TGF-ß1 and collagen-type-1 measurement using an enzyme-linked immunosorbent assay (ELISA). The fibrotic tissue of each rat was then collected and assessed histopathologically with the metavir scoring system. Results: Penile TGF-ß1 concentration in the losartan-treated group was not significantly different on day 10 and day 28 of observation (p10=0,30; p28=0,17). Meanwhile, collagen-type-1 concentration was significantly lower compared to control group (p10=0,002; p28=0,01). There was a significant difference in metavir scores in rats that received losartan and those who did not (p<0,05). Conclusion: Losartan could suppress the fibrosis process in the priapism model. It could decrease the collagen type 1 deposition during corpora cavernosa tissue regeneration. Based on the metavir score, the group receiving losartan therapy was better than the control group.


Subject(s)
Losartan , Priapism , Humans , Male , Rats , Animals , Losartan/pharmacology , Losartan/therapeutic use , Angiotensin Receptor Antagonists/pharmacology , Angiotensin Receptor Antagonists/therapeutic use , Priapism/pathology , Transforming Growth Factor beta1/metabolism , Rats, Wistar , Angiotensin-Converting Enzyme Inhibitors , Penis , Fibrosis , Collagen
3.
Urol Case Rep ; 33: 101378, 2020 Nov.
Article in English | MEDLINE | ID: mdl-33102076

ABSTRACT

Complete urethral disruption due to urethral catheterization is rarely documented. Only seven cases of iatrogenic complete urethral disruption were reported from 1997 to 2003. We describe a case of complete urethral disruption due to urethral catheterization in an 80-year-old male who was referred because of a scrotal mass. Physical examination showed a palpable non-fluctuation mass in the scrotum and ultrasound examination revealed an intrascrotal balloon catheter. This was an obscure case of urethral catheterization complication presenting as a scrotal mass in an octogenarian patient with Fournier's gangrene.

4.
BMJ Qual Saf ; 25(6): 457-65, 2016 06.
Article in English | MEDLINE | ID: mdl-26294689

ABSTRACT

BACKGROUND: Interruptions to nursing workload may contribute to procedural failures and clinical errors impacting quality/safety of care, but the impact of interruptions on the duration of these activities has not been closely scrutinised. This study analyses the effect of interruptions to care provided by nurses and clinical technicians on the length of clinical procedures and interventions (excluding the length of the interruption). METHODS: An observational time study of the effect of interruptions on common nursing interventions in the emergency department (ED) of a large academic medical centre was conducted. This study used direct observations of nurses and clinical technicians while delivering care to patients. RESULTS: The average time spent on an uninterrupted intervention was 296.47 s (median:185.15, SD:319.05), while interrupted interventions took 682.02 s (median:589.63, SD:504.59). Controlling for intervention type and other potential confounding factors using multiple linear regression found that interrupted interventions were 121.36 s (95% CI 79.57 to 163.15) longer, a 19 percentage point increase (95% CI 11.31 to 26.89), than an intervention without (excluding the length of the interruption). Family/patient interruptions effected duration the most while staff interruptions affected the intervention time the least. DISCUSSION: Our findings are consistent with outcomes of studies in non-healthcare domains, but are contrary to a study of ED physicians, suggesting differential responses to interruptions by physicians and nurses. Future studies on interruptions in healthcare should thus be discipline specific. Though the effect of interruptions on intervention length is only about 2 min, in an ED setting, this can increase patient risks and costs. To better focus efforts to reduce interruptions future research should focus on further separation of interruption type (eg, urgent vs routine or unnecessary).


Subject(s)
Emergency Nursing , Emergency Service, Hospital , Workload/statistics & numerical data , Emergency Nursing/standards , Humans , Medical Errors , Time and Motion Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...